Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection

por Alshoubaki, Osama, AL Darabaa, Ziad, Odat, Omar, Qubbaj, Ashraf, Alhyari, Ramzi, Alshare, Sakher, Ghanma, Issa
Publicado 2021

Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma

por Al-Odat, Omar S., Guirguis, Daniel A., Schmalbach, Nicole K., Yao, Gabriella, Budak-Alpdogan, Tulin, Jonnalagadda, Subash C., Pandey, Manoj K.
Publicado 2022

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

por Al-Odat, Omar S., von Suskil, Max, Chitren, Robert J., Elbezanti, Weam O., Srivastava, Sandeep K., Budak-Alpddogan, Tulin, Jonnalagadda, Subash C., Aggarwal, Bharat B., Pandey, Manoj
Publicado 2021

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

por Von Suskil, Max, Sultana, Kazi Nasrin, Elbezanti, Weam Othman, Al-Odat, Omar S., Chitren, Robert, Tiwari, Amit K., Challagundla, Kishore B., Srivastava, Sandeep Kumar, Jonnalagadda, Subash C., Budak-Alpdogan, Tulin, Pandey, Manoj K.
Publicado 2021

Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cell...

por Elbezanti, Weam Othman, Al-Odat, Omar S., Chitren, Robert, Singh, Jaikee Kumar, Srivastava, Sandeep Kumar, Gowda, Krishne, Amin, Shantu, Robertson, Gavin P., Nemmara, Venkatesh V., Jonnalagadda, Subash C., Budak-Alpdogan, Tulin, Pandey, Manoj K.
Publicado 2022